Prescribing Pattern of Sunitinib in Advanced Renal Cell Carcinoma Patients in Taiwan
碩士 === 國立成功大學 === 臨床藥學與藥物科技研究所 === 104 === Background Renal cell carcinoma (RCC) is a kind of malignancy originated within the kidneys, which has an increasing incidence in Taiwan. In these years, some new drugs were approved for RCC treatment, while tyrosine kinase inhibitors (TKI) are recommended...
Main Authors: | , |
---|---|
Other Authors: | |
Format: | Others |
Language: | zh-TW |
Published: |
2016
|
Online Access: | http://ndltd.ncl.edu.tw/handle/32822844525072164260 |